| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protara Therapeutics, Inc. (TARA) has 14 insiders with recent SEC Form 4 filings, including 3 buys and 14 sells. TARA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 524.0K | $2.75M | - | |
| CFO | 175.0K | $919.6K | - | |
| Other | 158.0K | $830.3K | - | |
| Other | 94.8K | $498.3K | - | |
| Other | 76.0K | $399.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2020 | Opaleye Management Inc.59 | 10% Owner | Buy | 300,000 | $16.87 | $5,061,000.00 | +13.6% | |
| Sep 22, 2020 | Davis Blaine75 | Chief Financial Officer | Buy | 1,481 | $16.91 | $25,037.79 | New | |
| Sep 14, 2020 | Marshall Randall | Former 10% Owner | Sell | 2,554 | $19.40 | $49,540.80 | -0.2% | |
| Sep 10, 2020 | Marshall Randall | 10% Owner | Sell | 239 | $18.00 | $4,302.00 | - | |
| Sep 9, 2020 | Marshall Randall | 10% Owner | Sell | 13,330 | $18.73 | $249,631.93 | -0.7% | |
| Sep 3, 2020 | Marshall Randall | 10% Owner | Sell | 259 | $20.58 | $5,330.64 | - | |
| Aug 28, 2020 | Marshall Randall | 10% Owner | Sell | 771 | $22.09 | $17,031.39 | -0.1% | |
| Aug 27, 2020 | Marshall Randall | 10% Owner | Sell | 2,034 | $22.39 | $45,543.12 | -0.2% | |
| Aug 25, 2020 | Marshall Randall | 10% Owner | Sell | 3,435 | $22.85 | $78,496.37 | -0.3% | |
| Aug 20, 2020 | Marshall Randall | 10% Owner | Sell | 510 | $24.18 | $12,333.33 | - |